Your browser doesn't support javascript.
loading
A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family.
Cui, Chong; Zhang, Luping; Qian, Fuping; Chen, Yuxin; Huang, Bowei; Wang, Fang; Wang, Daqi; Lv, Jun; Wang, Xuechun; Yan, Zhiqiang; Guo, Luo; Li, Geng-Lin; Shu, Yilai; Liu, Dong; Li, Huawei.
Afiliación
  • Cui C; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, China.
  • Zhang L; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Qian F; Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital, Nantong University, Nantong, China.
  • Chen Y; School of Life Sciences, Nantong Laboratory of Development and Diseases, Nantong University, Nantong, China.
  • Huang B; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, China.
  • Wang F; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Wang D; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, China.
  • Lv J; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Wang X; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, China.
  • Yan Z; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Guo L; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, China.
  • Li GL; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Shu Y; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, China.
  • Liu D; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Li H; Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital, Nantong University, Nantong, China.
Clin Genet ; 102(2): 149-154, 2022 08.
Article en En | MEDLINE | ID: mdl-35599357
The pathogenic variants in KCNQ4 cause DFNA2 nonsyndromic hearing loss. However, the understanding of genotype-phenotype correlations between KCNQ4 and hearing is limited. Here, we identified a novel KCNQ4 mutation p.G228D from a Chinese family, including heterozygotes characterized by high-frequency hearing loss that is progressive across all frequencies and homozygotes with more severe hearing loss. We constructed a novel murine model with humanized homologous Kcnq4 mutation. The heterozygotes had mid-frequency and high-frequency hearing loss at 4 weeks, and moved toward all frequencies hearing loss at 12 weeks, while the homozygotes had severe-to-profound hearing loss at 8 weeks. The degeneration of outer hair cells (OHCs) was observed from basal to apical turn of cochlea. The reduced K+ currents and depolarized resting potentials were revealed in OHCs. Remarkably, we observed the loss of inner hair cells (IHCs) in the region corresponding to the frequency above 32 kHz at 8-12 weeks. The results suggest the degeneration of OHCs and IHCs may contribute to high-frequency hearing loss in DFNA2 over time. Our findings broaden the variants of KCNQ4 and provide a novel mouse model of progressive hearing loss, which contributes to an understanding of pathogenic mechanism and eventually treatment of DFNA2 progressive hearing loss.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Canales de Potasio KCNQ / Pérdida Auditiva de Alta Frecuencia Tipo de estudio: Prognostic_studies Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Clin Genet Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Canales de Potasio KCNQ / Pérdida Auditiva de Alta Frecuencia Tipo de estudio: Prognostic_studies Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Clin Genet Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Dinamarca